It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 1991.
1991 | Mumbai, Maharashtra, India | Struck OffMedispec Pharmaceuticals Private Limited, a struck off private limited company, was established on 21 January 1991 in Mumbai, Maharashtra, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U24230MH1991PTC059904. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.90 Cr.
Its leadership includes Dotty Mohan (Additional Director), Somashekar Vegamadagu Suryanarayana Rao (Additional Director). Past directors included Sundaram Kodhandaramaiah, Rajesh Prahlad Bapat. It holds no open charges and ₹1.25 Cr settled loans. Its latest AGM occurred on 26 September 2016, with the balance sheet filed on 31 March 2016. It is based at # 10/2, Third Floor Of Chandrodaya Co-Operative Housing Society Limited, C.S.T. Road, Ch, Embur, Mumbai, Maharashtra, 400071.
U24230MH1991PTC059904
059904
21 January 1991
₹2.00 Cr
₹1.90 Cr
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Medispec Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dotty Mohan | Additional Director | 27 Dec 2016 | Current |
| Somashekar Vegamadagu Suryanarayana Rao | Additional Director | 27 Dec 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jan 2017 | Past |
| Pramod Abcsdd | Director | 14 Dec 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Medispec Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2016, Medispec Pharmaceuticals had a promoter holding of 0.01% and a public holding of 99.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹12,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Feb 2005 | State Bank Of Mysroe | ₹7.00 M | Satisfied |
| 13 Jul 1995 | State Bank Of Mysore | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medispec Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medispec Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medispec Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dotty Mohan was appointed as a Additional Director was appointed as a Additional Director on 27 Dec 2016 & has been associated with this company since 8 years 11 months . was completed.
Somashekar Vegamadagu Suryanarayana Rao was appointed as a Additional Director was appointed as a Additional Director on 27 Dec 2016 & has been associated with this company since 8 years 11 months . was recorded as a recent event.
The activity Medispec Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Sep 2016 as per latest MCA records. was completed.
The activity A charge registered on 10 Feb 2005 via Charge ID 90365566 with State Bank Of Mysroe was fully satisfied on 29 Jun 2016. was completed.
The activity A charge registered on 13 Jul 1995 via Charge ID 90363801 with State Bank Of Mysore was fully satisfied on 29 Jun 2016. was completed.
Progress on Medispec Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai. was documented.
The CIN of Medispec Pharmaceuticals Private Limited is U24230MH1991PTC059904.
Medispec Pharmaceuticals Private Limited is headquartered at # 10/2, Third Floor Of Chandrodaya Co-Operative Housing Society Limited, C.S.T. Road, Ch, Embur, Mumbai, Maharashtra, 400071.
Medispec Pharmaceuticals Private Limited was incorporated on 21 January 1991.
The current directors of Medispec Pharmaceuticals Private Limited are
The primary industry of Medispec Pharmaceuticals Private Limited is Chemicals.
Medispec Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medispec Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.90 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX